search
for
 About Bioline  All Journals  Testimonials  Membership  News


African Health Sciences
Makerere University Medical School
ISSN: 1680-6905 EISSN: 1729-0503
Vol. 5, Num. 3, 2005, pp. 261-264

African Health Sciences, Vol. 5, No. 3, September, 2005, pp. 261-264

CASE REPORTS

Extremity haemangiopericytoma, a case report from Nigeria

Lateef O. A Thanni

Department of Orthopaedics and Traumatology, College of Health Sciences, Olabisi Onabanjo University, Sagamu, Ogun State

Correspondence author : Lateef O. A Thanni Department of Orthopaedics and Traumatology, College of Health Sciences, Olabisi Onabanjo University, P.M.B. 2022 Sagamu, Ogun State Email : loathanni@yahoo.com

Code Number: hs05044

Abstract

Haemangiopericytoma is an uncommon soft tissue sarcoma of vascular origin. It occurs more frequently in the extremities than elsewhere in the body although it can arise in any organ. Wide surgical excision is the mainstay of treatment. However, adjuvant radiotherapy and chemotherapy are desirable because the malignant nature of this tumour is frequently unpredictable. Adjuvant therapy is recommended for metastases, recurrence and incomplete resection. Long term follow up is essential in all cases as recurrence can occur several years after treatment. Where little or no experience with managing this tumor exists, it is important to be aware of its clinical behaviour and the treatment options, hence this case reports.

Key words: haemangiopericytoma, sarcoma, tumour, radiotherapy, chemotherapy

Introduction

Haemangiopericytomas are soft tissue sarcomas of vascular origin, comprised of pericytes1. Stout and Murray first described the tumour in 1942 in the lungs2 but it can occur anywhere in the body. The tumour has been reported to occur in the extremities, pelvis3, head and neck4, back, retroperitoneum and abdomen5. Primary central nervous system occurrence has also been reported6. Manifestation in bone is extremely rare but has been reported in a foot bone7. This special tumor always shows a questionable prognosis and, by histological investigations, it cannot be decided if we are dealing with a benign or malignant tumour growth8. Enzinger and Smith9 have suggested that malignancy can be predicted from a large tumour size, presence of necrosis, increased cellularity and over 4 mitoses per high power field. However, clinical tumour behaviour and the occurrence of distant metas tasis may be the only way to confirm the malignant nature of the tumour. Metastasis or local recurrence may occur after several years. This is the first report of extremity haemangiopericytoma from our center. Where little or no experience with managing this tumor exists, it is important to be aware of its clinical behaviour and the treatment options, hence this case report.

Case Report

A 22 year old male patient was seen in March 2002 with a 3 month history of spontaneous right leg swelling. There was associated pain while walking but no pyrexia. It was slowly progressive in size until 2 weeks before presentation when a rapid increase in size was noted. There was no weight loss.

Examination revealed a healthy looking male patient with a 5cm by 5cm swelling on the posteromedial aspect of the right leg. It was firm, non tender and non pulsatile. Overlying skin was not warm and there was neither palpable popliteal lymphadenopathy nor significant inguinal lymphadenopathy.

Radiological examination of the affected leg showed soft tissue swelling but normal right tibia. Chest X-ray was normal. White blood cell count (WBC) revealed a relative lymphocytosis of 78% and neutropenia of 22% (total WBC 8500 per cumm). He was HIV negative.The patient thereafter defaulted for 5 months. By this time, the swelling was 12cm by 12cm when an incisional biopsy was done. The biopsy, on histological examination, showed cellular connective tissue neoplasm comprising proliferating spindle cells interspersed by prominent focally dilated vascular channels. There was low mitotic activity but mild pleomorphism but no area of necrosis. A diagnosis of haemangiopericytoma was made.

Excision of the tumour was performed about 7 months after initial presentation. A fungating soft tissue tumour was found, figure, attached to the lower fleshy part of the soleus muscle. The tumour was excised enbloc with overlying skin and a wide portion of the attached soleus muscle. The dorsal part of Achilles tendon was preserved. The posterior tibial neurovascular bundle was intact.

The wound healed primarily but a month postoperatively, a painful tender swelling developed in the scar and discharged pus from which pseudomonas specie was isolated. The swelling resolved with oral ciprofloxacin. He was referred for radiotherapy but did not commence this until about 9 months later. He was reported to have died suddenly of pulmonary complications while undergoing radiotherapy. Autopsy was reportedly not performed.

Discussion

Prediction of the clinical behaviour of haemangiopericytoma is considerably difficult. This may be because it is a heterogeneous entity with specific component variants that are yet to be identified. Lipomatous haemangiopericytoma is a benign variant that has more recently been described10. Identification of such variants will make management decision easier.

Wide surgical excision is the treatment of choice11,12,13. However because of the unpredictable malignant behaviour of the tumour, adjuvant therapy is desirable. Haemangiopericytoma is poorly radiosensitive but radiotherapy has been used with some success11,14. Primary and metastatic tumours are chemosensitive11. Chemotherapy with methotrexate, actinomycin D, Cyclophosphamide and vincristine in various combinations has also been used with success11. Combined radiotherapy and chemotherapy is to be recommended for metastasis, recurrence and inadequate excision.

Patient should be followed up regularly because of local and distant tumour recurrence15. Recurrence can occur several years after treatment, as long 26 years later16.

Pulmonary metastasis can be fatal due to complicating pneumothorax17 and haemothorax18. It is possible that the patient in this report died suddenly of such complications despite the fact that the tumour showed little mitotic activity and no area of necrosis. The delays in making a diagnosis and getting adjuvant radiotherapy, occasioned by the patient’s default in hospital attendance may have contributed significantly to the adverse outcome.

(Figure A, B)

References
  1. Hansen T, Gaumann A, Ghalibafian M, Hoferlin A, Heintz A, Kirkpatrick CJ. Haemangiopericytoma of the thyroid gland in combination with Hashimoto’s disease. Virchows Arch. 2004 Jul 9 [Epub ahead of print]
  2. Stout AP, Murray MR. Haemangiopericytoma, vascular tumour featuring Zimmerman’s pericytes. Ann Surg 1942; 116: 26
  3. Ahmad GF, Athavale R, Hamid BN, Davies-Humphreys J. Pelvic malignant hemangiopericytoma mimicking an ovarian neoplasm; a case report. J Reprod Med. 2004; 49: 404-7.
  4. Alhassan MB, Kyari F, Mohammed A. Haemangiopericytoma of the eyelid and orbit: report of 2 cases. Nigerian Journal of Surgical Research 2003; 5: 166-170.
  5. Pitluk HC, Conn J Jr. Hemangiopericytoma. Literature review and clinical presentations. Am J Surg. 1979; 137: 413-6.
  6. Spatola C, Privitera G. Recurrent intracranial hemangiopericytoma with extracranial and unusual multiple metastases: case report and review of the literature. Tumori. 2004; 90: 265-268.
  7. Derouin MR, Key JJ, Caminear DS, Sella E. Hemangiopericytoma of the navicular: a case report. J Foot Ankle Surg. 2004; 43: 191-4.
  8. Adler CP, Trager D. Malignant hemangiopericytoma-a soft tissue and bone tumor. Z Orthop Ihre Grenzgeb. 1989; 127: abstract
  9. Enzinger FM, Smith BH. Haemangiopericytoma: an analysis of 106 cases. Human Pathol 1976; 7: 61 – 62.
  10. Alrawi SJ, Deeb G, Cheney R, Wallace P, Loree T, Rigual N, Hicks W, Tan D. Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and dna ploidy analyses. Head Neck. 2004; 26: 544-9.
  11. Atkinson JB, Manhour GH, Isaacs H, Ortega JA. Haemangiopericytoma in infants and children. A report of six children. Am J Surg 1984; 148: 372 – 374.
  12. Gerner RE, Moore GE, Pickren JW. Haemangiopericytoma. Ann Surg 1974; 179: 128 – 132.
  13. Perugia D, Basile A, Massoni C, Barletta V. Haemangiopericytoma in the distal third of the arm. Int Orthop. 1999; 23: 184-6.
  14. Friedman M, Egan JW. Irradiation of haemangiopericytoma of Stout. Radiology.1960; 74: 721 – 729.
  15. Woitzik J, Sommer C, Krauss JK. Delayed manifestation of spinal metastasis: a special feature of hemangiopericytoma. Clin Neurol Neurosurg. 2003; 105: 159-66.
  16. Marcus L, Dillon MD. Haemangiopericytoma. In David C. Sabiston ed. Textbook of surgery, the biological basis of modern surgical practice. 13th edition. 1986. WB Saunders company, Philadelphia. P 2051.
  17. Yoshida J, Nakano T, Akao M, Tanimura A. Pneumothorax due to hemangiopericytoma metastasis from the thigh. Jpn J Thorac Cardiovasc Surg. 1998; 46: 523-5.
  18. Cheng YL, Yu CP, Hsu SH, Lee SC. Hemangiopericytoma of the pleura causing massive hemothorax. J Formos Med Assoc. 2000; 99: 428-30.

Copyright © 2005 - Makerere Medical School, Uganda


The following images related to this document are available:

Photo images

[hs05044fb.jpg] [hs05044fa.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil